BioSpace News Archive

ChromaDex Corp. (NASDAQ:CDXC), one of the global authorities on Nicotinamide Adenine Dinucleotide (NAD + ) and healthy aging research, shares results from a phase II clinical study published in the peer-reviewed journal, Movement Disorders, by a team of researchers led by Dr. Hilde Nilsen, University of Oslo, Arkershus University Hospital, Norway.

Envision Pharma Group unveils its AI Innovation Board and announces the appointment of Dr. Loubna Bouarfa as AI thought leader and Chairwoman of the newly established board.

Mainz Biomed N.V. announced the closing of its previously announced registered direct offering with several institutional investors to purchase $5.0 million of its ordinary shares and warrants to purchase ordinary shares.

Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal sodium) in combination with standard of care immune checkpoint blockade (CB) for the treatment of advanced cutaneous melanoma ( NCT02557321 ).

Scilex Holding Company announced that the U.S. Patent and Trademark Office has issued a new patent, No. 11,793,766, further strengthening the Company’s intellectual property position and coverage for its lead commercial product, ZTlido® 1.8%.

ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”): Today, a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes announced its financial and operating results for the third quarter of 2023.

Zynex, Inc. announced the Company has been ranked within Forbes’ list of America’s Most Successful Small-Cap Companies for 2024.

FSD Pharma Inc. is pleased to announce that it has provided certain additional disclosure, by way of a Supplement dated November 15, 2023 to its Management Information Circular dated October 20, 2023.

Octave® Bioscience, Inc. announced that it has been awarded a $10M grant from The Michael J. Fox Foundation for Parkinson’s Research.

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company”) is pleased to announce it has completed the previously announced (see Press Release November 7, 2023) acquisition of all of the shares of Triniti Trading Corp. an authorized distributor of TonyMoly products in Canada (o/a TonyMoly Canada), a highly renowned beauty and skincare brand, on November 14, 2023.